Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combinati...

بواسطة Librada Fortuna, Surasith Chaithongwongwatthana, Ngamphol Soonthornworasiri, Jane Spiegel, Wassana Wijagkanalan, Souad Mansouri, Anita H.J. van den Biggelaar, Hong Thai Pham
منشور في 2020

Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aP<inf>gen</inf> or combined TdaP<inf>gen</inf> vaccines

بواسطة Punnee Pitisuttithum, Jittima Dhitavat, Chukiat Sirivichayakul, Arom Pitisuthitham, Yupa Sabmee, Pailinrut Chinwangso, Chawanee Kerdsomboon, Librada Fortuna, Jane Spiegel, Mukesh Chauhan, Indrajeet Kumar Poredi, Anita H.J. van den Biggelaar, Wassana Wijagkanalan, Simonetta Viviani, Souad Mansouri, Hong Thai Pham
منشور في 2022

A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age

بواسطة Kulkanya Chokephaibulkit, Thanyawee Puthanakit, Niranjan Bhat, Souad Mansouri, Yuxiao Tang, Keswadee Lapphra, Supattra Rungmaitree, Suvaporn Anugulruengkitt, Watsamon Jantarabenjakul, Indah Andi-Lolo, Renee Holt, Librada Fortuna, Chawanee Kerdsomboon, Pailinrut Chinwangso, Ladda Suwitruengrit, Anita H.J. van den Biggelaar, Simonetta Viviani, Hong Thai Pham, Bruce L. Innis
منشور في 2022